Leap Therapeutics Inc (NASDAQ: LPTX) is -24.85% lower on its value in year-to-date trading and has touched a low of $1.24 and a high of $10.20 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LPTX stock was last observed hovering at around $3.04 in the last trading session, with the day’s gains setting it 0.08%.
Currently trading at $3.12, the stock is 22.23% and 10.96% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.67 million and changing 2.47% at the moment leaves the stock 23.72% off its SMA200. LPTX registered 3.83% gain for a year compared to 6-month gain of 94.69%. The firm has a 50-day simple moving average (SMA 50) of -$66.81 and a 200-day simple moving average (SMA200) of -$0.11.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 24.60% loss in the last 1 month and extending the period to 3 months gives it a -8.11%, and is 24.10% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 21.80% over the week and 12.90% over the month.
Leap Therapeutics Inc (LPTX) has around 54 employees, a market worth around $79.74M and $0.00M in sales. Distance from 52-week low is 152.23% and -69.46% from its 52-week high. The company has generated returns on investments over the last 12 months (-135.37%).
Leap Therapeutics Inc quarterly earnings per share for the current quarter are estimated at -$0.58.The EPS is expected to grow by 43.40% this year
52 institutions hold shares in Leap Therapeutics Inc (LPTX), with institutional investors hold 31.30% of the company’s shares. The shares outstanding are 25.57M, and float is at 23.43M with Short Float at 4.86%. Institutions hold 30.37% of the Float.
The top institutional shareholder in the company is Baker Brothers Advisors, LLC with over 1.17 million shares valued at $3.67 million. The investor’s holdings represent 4.59% of the LPTX Shares outstanding. As of Jun 29, 2023, the second largest holder is Cormorant Asset Management, LP with 1.07 million shares valued at $3.36 million to account for 4.20% of the shares outstanding. The other top investors are Rock Springs Capital Management, LP which holds 1.07 million shares representing 4.20% and valued at over $3.36 million, while Adage Capital Partners GP L.L.C. holds 3.69% of the shares totaling 0.94 million with a market value of $2.95 million.
